9.30 – 11.00 am: Are the metabolic syndrome and insulin resistance a breaking ground for innovation?

With the metabolic syndrome driving the twin global epidemics of type 2 diabetes it is imperative to tackle this issue, shop identify the challenges such as: patient stratification, systems biology and understanding of human metabolism, big data and ways to overcome them.  What can academia/industry and the clinic do together? Which collaboration models to put in place to speed up innovation?


Moderator: Michael Rossbach, VP Global Pharma Partnering, Vela Diagnostics, DE

  • Serge Bottari, Researcher, endocrinology, Grenoble-Alpes University, FR
  • Farzad Abdi-Dezfuli, Partner, Sarsia Seed Management, NO
  • Philippe Froguel, EGID, FR / Imperial Innovation, UK
  • Vered Caplan, CEO, Orgenesis, IL



2.30 – 4.00 pm: What are the needs of pharmas in terms of licensing and collaborative research in diabetes?

Hear from 3 pharma companies on which are their strategies, what they are looking for when scouting and in terms of licensing and collaborative research. Come and join them and get involved in the roundtable discussion following their presentations.

 Moderator: Stefanie Possekel, Director Technology Management, Ascenion, DE 

  • Tomas Landh, ?Innovation Sourcing VP, Novo Nordisk, DK
  • Mathias Urmann, Associate Vice-President, Sanofi, DE
  • Parth Chakrabarti, Sr. Director, New Ventures & Transactions, Johnson & Johnson Innovation, UK



4.30 – 5.30 pm:5 minutes to persuade (research projects & start-up pitches)

  • Serge Bottari, Researcher, endocrinology, Grenoble-Alpes University, FR
  • Tara Heitner, Director of Business Development, DiaCure, DK
  • Fredrik Ståhl, CEO, Dianovator, SE
  • Cornelia Richter, Post-Doc Researcher, University of Dresden, DE
  • Jaromir Zahradka, Project Manager, IOCB TTO, CZ



5.30 – 6.30 pm: Most successful & innovative start-ups in diabetes in 2015/2016

This session will discuss:

  • How to go from idea to form a company
  • What were the hurdles to overcome, what can be improved for the future?
  • The financing map of the company
  • Important deals/alliances with academia & big players


Moderator: John Carroll, Editor, Endpoints, USA

  • Ignacio Faus, CEO, Genmedica, ES
  • Richard Bouaoun, Director of Operations, Defymed, FR
  • Suren Chavan, CEO, Vicapsys, USA


Conference Programme Manager

+33 (0) 359 390 184


image ramona

Continue your tour





30th Nov. – 1st Dec. 2016